Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Seres Therapeutics, Inc. (MCRB) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
08/16/2023 EFFECT Form EFFECT - Notice of Effectiveness:
08/08/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "Seres Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates"
05/10/2023 SC 13G/A FEDERATED HERMES, INC. reports a 9% stake in SERES THERAPEUTICS, INC.
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Investor presentation, Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Seres Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates",
"Seres Therapeutics, Inc. Corporate Presentation as of May 2023",
"Seres Therapeutics, Inc. SER-155 Phase 1b Cohort 1 Study Results Slide Presentation as of May 2023",
"Seres Therapeutics Reports SER-155 Phase 1b Cohort 1 Results Showing Successful Drug Bacteria Engraftment and Substantial Reduction in Pathogen Domination in the Gastrointestinal Microbiome"
04/27/2023 8-K Quarterly results
04/25/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/25/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/14/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/06/2023 SC 13G/A BlackRock Inc. reports a 5% stake in Seres Therapeutics, Inc.
03/07/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/07/2023 10-K Annual Report for the period ended December 31, 2022
03/07/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Seres Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates"
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A FMR LLC reports a 15% stake in SERES THERAPEUTICS INC
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 4.9% stake in Seres Therapeutics Inc.
02/03/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/03/2023 SC 13G BlackRock Inc. reports a 5.2% stake in Seres Therapeutics, Inc.
02/01/2023 SC 13G/A FEDERATED HERMES, INC. reports a 14.5% stake in SERES THERAPEUTICS, INC.
01/09/2023 8-K Investor presentation
Docs: "Seres Therapeutics, Inc. Corporate Presentation as of January 2023",
"Seres Therapeutics, Inc. Corporate Presentation as of January 2023"
01/05/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/30/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
12/14/2022 8-K Quarterly results
11/02/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/02/2022 8-K Quarterly results
08/09/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/03/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/03/2022 8-K Quarterly results
Docs: "Seres Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates"
07/22/2022 SC 13D/A Nestle Health Science US Holdings, Inc. reports a 6.1% stake in Seres Therapeutics, Inc.
07/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
07/07/2022 SC 13D/A Flagship VentureLabs IV, LLC reports a 18.9% stake in Seres Therapeutics, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy